Celltrion holdings Nasdaq

South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....

South Korea will be included in a global major bond index next year to attract an estimated $66 billion in capital inflows to Asia’s fourth-la...

Nearly half of South Korean startups hold negative views on the country’s startup ecosystem, citing the prolonged startup funding winter and t...

Celltrion Inc., South Korea’s largest biosimilar maker, said on Monday that it completed the establishment of a local subsidiary in Vietnam....

Within just two hours of the opening of the 13th Seoul Record Fair last Saturday, the waitlist for new LP records reached 1,500. There were 20 new r...

The Asan Nanum Foundation announced on Wednesday that it will hold a demo day for “The Chung Ju-yung Startup Competition” on Nov. 7 at C...

Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...

Celltrion Inc., South Korea’s largest biosimilar maker, will spend several billion dollars to build a factory to crack the contract developmen...

South Korea’s biosimilar maker Celltrion Inc. will venture into the contract development and manufacturing organization (CDMO) market, the com...

South Korea’s leading retailers, including Coupang Inc., are ramping up their logistics capacities to counter aggressive forays into the count...

South Korea's Lotte Group holds "2024 Korea Shopping Festa with Lotte" in Hanoi, Vietnam. The group and the Korean Ministry of SMEs and Startup...

South Korea’s central bank held interest rates steady but cut its inflation and growth forecasts for the year and signaled that it will pivot ...

Yanolja Co., South Korea’s leading travel and accommodation booking platform operator, may delay its Nasdaq initial public offering plan due t...

Samyang Roundsquare, the holding company of South Korea's Samyang Group, said on Friday that it recruits foreign interns with the potential for full...

Korea Investment Management Co. said on Thursday that the net assets of its ACE US Nasdaq 100 Exchange-Traded Fund (ETF) had surpassed 1 trillion wo...

EcoPro BM Co., a South Korean cathode materials producer, said on Tuesday it has signed a memorandum of understanding (MOU) with GEM, a Chinese batt...

Foreigner-only casino operators in South Korea reported weaker-than-expected operating profit in the second quarter as prolific gamblers traveling f...

South Korea’s largest biosimilar maker Celltrion Inc. said on Friday that it has scrapped a plan to merge with Celltrion Pharm Inc., an R&...

Hanwha Aerospace Co., South Korea’s answer to Elon Musk’s SpaceX, has decided to separate its non-core units to concentrate on the defen...

South Korea’s top travel and accommodation booking platform operator Yanolja Co. is seeking to streamline and restructure its affiliates to bo...

South Korea's Celltrion Inc. announced on Tuesday that its autoimmune disease treatment Yuflyma (Low WAC, active ingredient adalimumab) is now avail...

Celltrion Inc., South Korea’s biosimilar giant, will proceed with phase 3 trials for global blockbuster drug Keytruda’s copycat CT-P51, ...

Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump ...

Samyang Roundsquare, formerly known as Samyang Foods Group in South Korea, announced on Friday that it held a consumer event called the "Buldak Spic...

South Korea’s major chemical materials producer Kolon Industries Inc. is set to invest 129.6 billion won ($94.2 million) to establish an indus...

South Korea's CJ Group announced on Thursday that it will hold a "CJ K-festa" in Vietnam from Aug. 10 to Sept. 1, focusing on food, sports and movie...

South Korean biosimilar maker Celltrion Inc. said on Monday that its subcutaneous injection formulation for autoimmune diseases, Zymfentra (inflixim...

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...

South Korea's Kumho Tire Co. announced on Friday that it held the Kumho Dealer Convention event from July 20 to 22 in Sao Paulo, Brazil, inviting ab...

South Korea’s largest biosimilar maker Celltrion Inc. said on Tuesday that its third plant in Sondgo, west of Seoul, is undergoing process val...